| Detected | Trial | Change |
|---|---|---|
| 2026-08-04 | NCT07185997 Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's… |
Trial sites expanded: 78 -> 88 locations |
| 2026-07-28 | NCT07066657 A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors |
Enrollment increased: 405 -> 572 participants |
| 2026-07-28 | NCT07066657 A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors |
Trial arms changed: 1 -> 2 |
| 2026-07-28 | NCT07066657 A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors |
date change Primary completion moved earlier: 2029-05 -> 2028-03 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-10 | NCT07755436 Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and… | Phase 1 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07185997 | Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's… | Non-Small-Cell Lung Cancer | Recruiting |
| NCT05607550 | Study to Compare Furmonertinib to Platinum-Based Chemotherapy for Patients With Locally… | Metastatic Non-Small Cell Lung Cancer | Active, Not Recruiting |
| Phase 1 | |||
| NCT07755436 | Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and… | Ovarian Cancer | Recruiting |
| NCT07066657 | A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors | Locally Advanced or Metastatic Solid Tumors | Recruiting |
| NCT05364073 | Study of Furmonertinib in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer… | Non-Small Cell Lung Cancer (NSCLC) | Active, Not Recruiting |